|
depression |
20 |
|
anxiety |
12 |
|
covid-19 |
12 |
|
network analysis |
12 |
|
population-based |
10 |
|
alkaline phosphatase |
7 |
|
antidepressants |
7 |
|
biliary |
7 |
|
cholangiogram |
7 |
|
coping strategies |
7 |
|
correlates |
7 |
|
diabetes complications |
7 |
|
diabetes mellitus |
7 |
|
ketamine |
7 |
|
loneliness |
7 |
|
magnetic resonance cholangiography |
7 |
|
mental disorders |
7 |
|
mortality |
7 |
|
post-complication mortality |
7 |
|
post-traumatic stress disorder |
7 |
|
pre-existing mental disorders |
7 |
|
pregnancy |
7 |
|
psychiatric patients |
7 |
|
psychopathology |
7 |
|
social support |
7 |
|
substance abuse |
7 |
|
suicidal ideation |
7 |
|
survey |
7 |
|
coping styles |
6 |
|
self-reported cognitive complaints |
6 |
|
traumatic stress symptoms |
6 |
|
bipolar disorder |
4 |
|
congenital malformations |
4 |
|
delivery complications |
4 |
|
hong kong |
4 |
|
men who have sex with men |
4 |
|
mood stabilizers |
4 |
|
neonatal outcomes |
4 |
|
obstetric complications |
4 |
|
pre-exposure prophylaxis |
4 |
|
prenatal exposure |
4 |
|
antipsychotic |
3 |
|
cardiac heart defects |
3 |
|
discontinuation |
3 |
|
pharmaco-epidemiology |
3 |
|
second-generation antipsychotics |
3 |
|
teratogenicity |
3 |
|
aripiprazole |
2 |
|
asia |
2 |
|
clinical trials |
2 |
|
consensus statement |
2 |
|
crossover design |
2 |
|
hiv |
2 |
|
hiv prevention |
2 |
|
hiv prevention trials |
2 |
|
human immunodeficiency virus |
2 |
|
implementation science |
2 |
|
msm |
2 |
|
prep |
2 |
|
qualitative analysis |
2 |
|
seasonal influenza |
2 |
|
acquired immune deficiency syndrome |
1 |
|
acquired immunodeficiency syndrome |
1 |
|
adherence |
1 |
|
aids |
1 |
|
antiretroviral |
1 |
|
blood safety |
1 |
|
cd4-positive t-lymphocytes |
1 |
|
clinical cohort |
1 |
|
drug use pattern |
1 |
|
elderly |
1 |
|
hcv |
1 |
|
hcv genotyping |
1 |
|
healthcare workers |
1 |
|
hepatitis c prevalence |
1 |
|
hiv infections |
1 |
|
hiv seroconversion |
1 |
|
hiv/aids |
1 |
|
homosexuality, male |
1 |
|
household structure |
1 |
|
idu |
1 |
|
injection drug users |
1 |
|
injection drug users (idus) |
1 |
|
leukocyte count |
1 |
|
medical education |
1 |
|
methadone |
1 |
|
methadone treatment |
1 |
|
mhealth |
1 |
|
multilevel |
1 |
|
penicillium |
1 |
|
phylogenetic analysis |
1 |
|
prep failure |
1 |
|
prevalence |
1 |
|
rectal |
1 |
|
self-deferral |
1 |
|
self-sampling |
1 |
|
sexual behavior |
1 |
|
sexual behaviour |
1 |
|
social network |
1 |
|
social space |
1 |
|
sti testing |
1 |
|
transfusion |
1 |
|
vaccination |
1 |
|
vaccine uptake rate |
1 |
